Understanding genetic syndromes linked to RNU4ATAC mutations
Official title: Study of the Consequences of Mutations of the RNU4ATAC and RTTN Genes by Transcriptomic, Biochemical and Cellular Approaches in Order to Determine the Pathophysiology of Their Associated Syndromes: Microcephalic Osteodysplastic Primordial Dwarfism Type I/III, Roifman Syndrome and Lowry-Wood Syndrome
Run by Hospices Civils de Lyon · NCT06111950 · Data updated 2026-11-12
This study is trying to understand how changes in the RNU4ATAC gene affect rare genetic syndromes like Taybi Linder Syndrome and Roifman Syndrome, which can cause growth and developmental problems.
Quick facts
| Study type | Interventional |
|---|---|
| Sex | All |
| Enrollment | 45 (estimated) |
| Sponsor | Hospices Civils de Lyon Academic / other |
| Locations | 6 sites (Bordeaux and 5 other locations) |
| Status | Recruiting |
| Started | August 27, 2024 |
| Main results expected | August 27, 2029 |
| Study ends | August 27, 2029 |
| Registry record updated | October 9, 2024 |
| Trial ID | NCT06111950 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals diagnosed with Taybi Linder Syndrome, Roifman Syndrome, Lowry Wood Syndrome, or other related conditions with specific RNU4ATAC mutations.
✕Probably not a fit
Patients without bi-allelic mutations of RNU4ATAC or RTTN, or those not diagnosed with the specified syndromes, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the pathophysiology of rare genetic syndromes associated with mutations in the RNU4ATAC gene, which is involved in the minor spliceosome. It focuses on conditions such as Taybi Linder Syndrome, Roifman Syndrome, and Lowry Wood Syndrome, which are characterized by growth retardation, microcephaly, and other developmental issues. The research involves collecting blood samples, skin biopsies, and fetal samples to explore the impact of minor splicing defects on U12 genes that are crucial for primary cilia function. The goal is to better understand the cellular mechanisms affected by these mutations.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and potential treatments for patients with these rare genetic syndromes.
How similar studies have gone: While this approach is novel in its specific focus on RNU4ATAC mutations, similar studies on genetic syndromes have shown promise in understanding underlying mechanisms.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: TALS, RFMN, LWS or other pathology patients * Woman or man * All ages * Presence of bi-allelic mutations of RNU4ATAC or RTTN * Written consent of parents or legal guardian(s) * Affiliation to a Social Security scheme Healthy participants (Parent of the patient) * Woman or man * Major * Presence of mono-allelic mutations of RNU4ATAC * Written consent of the participant * Affiliation to a Social Security scheme Parents having recourse to a medical termination of pregnancy or having had a spontaneous miscarriage (for fetus samples) * Woman or man * Major * Presence of bi-allelic mutations of RNU4ATAC or RTTN in the fetus * Written parental consent * Affiliation to a Social Security scheme Exclusion Criteria: Subject participating in another research including an exclusion period still in progress.
Where it's running
-
Centre de référence anomalies du développement de Lyon, Hôpital Femme Mère Enfant
Bron, France Recruiting -
Centre de référence des anomalies du développement et syndromes malformatifs du Sud-Ouest Occitanie Réunion, CHU de Bordeaux-GH Pellegrin
Bordeaux, France Not yet recruiting -
Centre de référence des anomalies du développement et syndromes malformatifs de l'Est, CHU de DIJON
Dijon, France Not yet recruiting -
Centre de référence des anomalies du développement et syndromes malformatifs de l'inter région Nord-Ouest, Hôpital J de Flandre
Lille, France Not yet recruiting -
Unité Fonctionelle d'embryo-fœtopathologie, Hôpital Necker-Enfants Malades
Paris, France Not yet recruiting -
Centre de référence des anomalies du développement et syndromes malformatifs de l'Ouest, Hôpital Sud
Rennes, France Not yet recruiting
Study contacts
- Study coordinator: Sylvie MAZOYER, Dr
- Email: sylvie.mazoyer@inserm.fr
- Phone: 04 81 10 65 33
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Blood viscosity in ARDS: a look at how thick the blood is
This study tests whether blood viscosity is higher in adults with ARDS and whether viscosity relates to their breathing and blood flow issues.
-
Virus interactions in hospitalized patients during winter seasons in Lyon
This study tests all virological results from hospitalized patients in Lyon during winter to see how different respiratory viruses may co-occur or exclude each other.
-
Surgical Use of Efanoctocog alfa in Hemophilia A Patients
This observational study looks at how efanesoctocog alfa (Altuvoct) is used around surgery in people with hemophilia A to see if it helps control bleeding.
-
Sleep quality and its determinants during the liver transplant pathway
This study tests how sleep quality changes from before liver transplantation to six months after, in adults on the transplant waitlist at a single hospital.
-
Compare Trans-Stomal Bladder Lithotripsy Methods in Continent Catheterizable Urinary Reservoirs
This study looks at different ways to break up bladder stones in people with continent catheterizable urinary diversions to see which method works best when the normal route isn’t available.
-
French version validation of the New Mobility Score for older adults after hip fracture
This study tests whether the French version of the New Mobility Score accurately measures mobility in French patients aged 75 and older after hip fracture.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.